|Last Price||Today's Change||52-Week Range||Trading Volume|
|41.43||0.27 (+0.66%)||22.71 - 49.23||979.7 thousand|
Market data as of 4:00PM 12/10/13. Quotes are delayed by at least 15 min.
Seattle Genetics and Takeda Highlight Long-term Follow-up Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Clinical Trials in Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma at ASH 2013
12/09/2013 11:23 AM ET